Potassium negatively regulates angiotensin II type 1 receptor expression in human adrenocortical H295R cells

Hypertension

Volumn 25, Issue 6, 1995, Pages 1129-1134

  Bird, Ian M ^b   Word, R Ann ^a   Clyne, Colin ^a   Mason, J Ian ^a   Rainey, William E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

adrenal; angiotensin II; calcium; human; potassium; receptor

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ADENYLATE CYCLASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN II I 125; ANGIOTENSIN II [5 ISOLEUCINE]; BUCLADESINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; FORSKOLIN; MESSENGER RNA; NIFEDIPINE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; POTASSIUM CHLORIDE;

ADRENAL CORTEX CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; RNA ANALYSIS;

EID: 0029057413     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.25.6.1129     Document Type: Article

References (25)

1. Wong PC, Price WA Jr, Chiu AT, Carini DJ, Duncia JV, Johnson AL, Wexler RR, Timmermans PBMWM. Nonpeptide angiotensin II receptor antagonists: studies with EXP9270 and DuP 753. Hypertension. 1990;15:823-834.
2. Inagami T, Harris RC. Molecular insights into angiotensin II receptor subtypes. News Physiol Sci. 1993;8:215-218.
3. Sandberg K. Structural analysis and regulation of angiotensin II receptors. Trends Endocrinol Metab. 1994;5:28-35.
4. Naville D, Lebrethon MC, Kermabon AY, Rouer E, Benarous R, Saez JM. Characterisation and regulation of angiotensin II type-1 receptor (binding and mRNA) in human adrenal fasciculata reticularis cells. FEBS Lett. 1993;312:776-782.
5. Bird IM, Hanley NA, Word AR, Mathis JM, McCarthy JL, Mason JI, Rainey WE. Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin II-responsive aldosterone secretion. Endocrinology 1993;133:1555-1561.
6. Bird IM, Mason JI, Rainey WE. Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology. 1994;134:2468-2474.
7. Makita N, Iwai N, Inagami T, Badr KF. Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem Biophys Res Commun. 1992;185:142-146.
8. Iwai N, Inagami T. Regulation of the expression of rat angiotensin II receptor mRNA. Biochem Biophys Res Commun. 1992;182: 1094-1099.
9. Iwai N, Inagami T, Ohmichi N, Nakamura Y, Saeki Y, Kinoshita M. Differential regulation of rat AT1a and AT1b receptor mRNA. Biochem Biophys Res Commun. 1992;188:298-303.
10. Lehoux JG, Bird IM, Rainey WE, Tremblay A, DuCharme L. Both low sodium and high potassium intake increase the level of adrenal angiotensin-II receptor type 1, but not that of adrenocorticotropin receptor. Endocrinology. 1994;134:776-782.
11. Konishi H, Kuroda S, Inada Y, Fujisawa Y. Novel subtype of human angiotensin II type 1 receptor: cDNA cloning and expression. Biochem Biophys Res Commun. 1994;199:467-474.
12. Rainey WE, Bird IM, Mason JI. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol Cell Endocrinol. 1994;100:45-50.
13. Quinn SJ, Williams GH. Regulation of aldosterone secretion. In: James VHT, ed. The Adrenal Gland. 2nd ed. New York, NY: Raven Press Publishers; 1992:159-189.
14. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
15. Tsien RY, Pozzan T, Rink TJ. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new intracellularly trapped fluorescent indicator. J Cell Biol. 1982;94:325-334.
16. Taylor DA, Stull JT. Calcium dependency of myosin light chain phosphorylation in smooth muscle cells. J Biol Chem. 1988;263: 14456-14462.
17. Douglas JG. Effects of high potassium diet on angiotensin II receptors and angiotensin-induced aldosterone production in rat adrenal glomerulosa cells. Endocrinology. 1980;106:983-990.
18. Aguillera G, Hauger RL, Catt KJ. Control of aldosterone secretion during sodium restriction: adrenal receptor regulation and increased adrenal sensitivity to angiotensin II. Proc Natl Acad Sci U S A. 1978;75:975-979.
19. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989;165:196-203.
20. 125I]angiotensin II binding sites in rat adrenal gland. Regul Pept. 1988;23:127-133.
21. 1 receptor. Am J Physiol. 1993;264:F989-F995.
22. Rainey WE, Oka K, Magness RR, Mason JI. Ovine fetal adrenal synthesis of cortisol: regulation by ACTH, angiotensin II and transforming growth factor beta. Endocrinology. 1991;129:1784-1790.
23. Bird IM, Magness RR, Mason JI, Rainey WE. Angiotensin-II acts via the type 1 receptor to inhibit 17α-hydroxylase cytochrome P450 expression in ovine adrenocortical cells. Endocrinology. 1992;130: 3113-3121.
24. Mason JI, Bird IM, Rainey WE. Regulation of adrenal 3β-hydroxysteroid dehydrogenase/Δ5→4-isomerase and P45017 α-hydroxylase expression. In: Saez JM, Brownie AC, Capponi A, Chambaz EM, Mantero F, eds. Cellular and Molecular Biology of the Adrenal Cortex. Colloque INSERM/John Libbey Eurotext Ltd; 1992;222:111-122.
25. Bakke M, Lund J. A novel 3′,5′-cyclic adenosine monophosphate-responsive sequence in the bovine CYP17 gene is a target of negative regulation by protein kinase C. Mol Endocrinol. 1992;6: 1323-1331.